Ahmad and Garg have noted the similarity in the proportion of APOB R3500Q carriers and noncarriers with a history of self-reported cardiovascular events and questioned whether the lack of difference could be an artifact of survival bias or alternatively could reflect a lack of association between the mutation and excess cardiovascular morbidity, despite the mutation being associated with increased LDL-C levels and coronary artery calcification. We suspect that the mutation does have an impact on mortality rates based on our preliminary analysis of all-cause mortality in relatives of our study subjects whom we can infer to be mutation carriers. In our Amish population we identified 14 relatives of study subjects (mostly parents) who, although deceased, could unambiguously be inferred as APOB R3500Q carriers. The mean (SD) age at death in these 14 obligate carriers was 68.6 (15.6) years, with a range of 39 to 90 years. In contrast, we have estimated the mean (SD) age at death among Amish from Lancaster County, Pennsylvania, born between 1908 and 1920 to be 77.6 (13.5) years, based on 539 deaths. While we recognize that the number of deaths we have observed among obligate APOB R3500Q carriers is small, our best guess at present is that the APOB R3500Q mutation probably is associated with decreased lifespan and that the lack of difference in self-reported cardiovascular events observed between R3500Q carriers and noncarriers in our study is probably an artifact of the relatively young age of many of our study subjects and/or a survival bias.
Mitchell BD, Shen H, Shields K, Shuldiner AR. Lack of Cardiovascular Disease Among Old Order Amish With Familial Defective Apolipoprotein B—Reply. Arch Intern Med. 2011;171(11):1039–1040. doi:10.1001/archinternmed.2011.239
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: